Nanomix
HCID Member | Medical Devices & Tech
5980 Horton Street, Suite 600
Emeryville, CA 94608 USA
phone: 510-428-5300
fax: 510-658-0425
Symbol Private
Founded 0
Employees
www.nano.com
Research Sector Medical Devices & Tech
Summary Description
Nanoelectronics-based devices for respiratory and biodetection applications
Management
David L. Macdonald, President & Chief Executive Officer; Dr. Marvin L. Cohen, Chief Scientific Officer; Scott Schroeder, Vice President, Finance & Chief Financial Officer; Matthew W. Powell, Vice President, Operations, Quality and Regulatory Affairs; William A. Perry, Vice President, Sales, Marketing & Business Development; Dr. Ying-Lan Chang, Vice President, Platform Development; Robert F. Dennis, Esq., Intellectual Property Counsel; Mr.Garrett Gruener:CEO
Keywords
diagnostics, breath analysis, nanotechnology, nanoelectronic, virus, Co2, DNA, industrial, bio, adv2007, advamed, biomolecule analysis, j2008

Comment | Printable Version | Dec. 26, 2008
If you work for Nanomix and want to update this profile, click here

Description
Nanomix is a nanoelectronic detection company specializing in handheld and point-of-care detection devices for respiratory and biodetection applications. The company's biodetection solutions offer low power consumption, small size, ultra-sensitivity and other performance advantages providing medical professionals with simplified conventional test protocols and routine access to critical information.
Products / Services
The Nanomix respiratory detection device pipeline includes: the Nanomix asthma monitor, a small, inexpensive device measuring expired quantities of nitric oxide (NO); the CapLite Single-use capnometer, which measures exhaled levels of carbon dioxide (CO2) using the company's proprietary Sensation platform; and the CapLite, a portable, single-use CO2 monitor for emergency airway management. Additionally, the Nanomix NanoTectTM monitors rely on a proprietary nanoelectronic platform to detect low levels of industrial gas for environmental monitoring and demand controlled ventilation. Coordination with ventilation control systems enables real-time modulation of the environment for high-value applications. Target applications for the company's biomolecule products include the electronic detection of genetically modified organisms in crop samples as well as the detection of human genetic patterns for diagnoses of infectious diseases, inherited diseases, and drug metabolism.
Technology / Differentiation
The Nanomix Sensation technology is a nanoelectronic detection platform based on carbon nanotube networks and proprietary chemistries. Its tiny detector chips are equipped with one or more individually addressable detection elements, each capable of being independently functionalized for the detection of a specific target analyte.
Market / Customers
The Nanomix asthma monitoring device currently targets the 20 million Americans living with asthma.
Status
Nanomix announced the issuance of an additional U.S. patent for its Sensation nanostructured detection platform in January 2008.


2009-01-07-2169